Medical News

RSS

James Allison to be honored with 2015 Pezcoller Foundation-AACR International Award for Cancer Research

The 2015 Pezcoller Foundation-American Association for Cancer Research (AACR) International Award for Cancer Research will be presented to James P. Allison, PhD, at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22.

17 Apr 2015

Aspirin use continues to surge among older adults in US

A national survey suggests that slightly more than half of the older adults in the United States are now taking a daily dose of aspirin, even though its use is not recommended by the Food and Drug Administration for most people who have not yet had a heart attack or stroke.

17 Apr 2015

Zinc deficiency can activate Hedgehog signaling pathway

Zinc deficiency - long associated with numerous diseases, e.g. autism, lung cancer, prostate cancer, and ovarian cancers - can lead to activation of the Hedgehog signaling pathway, a biomolecular pathway that plays essential roles in developing organisms and in diseases, according to new research at Rensselaer Polytechnic Institute.

17 Apr 2015

Study could lead to new therapeutic targets for treating Huntington's disease

An international study led by researchers from Université Laval and CHU de Québec-Université Laval has identified significant vascular changes in the brains of people with Huntington's disease. This breakthrough, the details of which are published in the most recent issue of Annals of Neurology, will have significant implications for our understanding of the disease and could open the door to new therapeutic targets for treating this fatal neurodegenerative condition.

17 Apr 2015

Donald S. Coffey to receive Margaret Foti Award at AACR Annual Meeting 2015

Donald S. Coffey, PhD, will be honored with the ninth annual American Association for Cancer Research Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22.

17 Apr 2015

New method for measuring genetic variability may help identify patients with aggressive cancers

A new method for measuring genetic variability within a tumor might one day help doctors identify patients with aggressive cancers that are more likely to resist therapy, according to a study led by researchers now at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

17 Apr 2015

CiRA, Takeda collaborate to develop clinical applications of iPS cells

Center for iPS Cell Research Application of Kyoto University and Takeda Pharmaceutical Company Limited announced today that they will work together to develop clinical applications of induced pluripotent stem cells in areas such as heart failure, diabetes mellitus, neurological disorders and cancer immunotherapy.

17 Apr 2015

Robert B. Kiningham receives Founders' Award at 2015 AMSSM Annual Meeting

Robert B. Kiningham, MD, was awarded the Founders' Award at the 24th American Medical Society for Sports Medicine Annual Meeting in Hollywood, Fla. The award is bestowed when AMSSM leadership determines that a member exemplifies the best that a sports medicine physician can be and do.

16 Apr 2015

Obesity in African-American men increases prostate cancer risk

Obesity has a profoundly different effect on prostate cancer risk in African-American as compared to non-Hispanic white men. Obesity in black men substantially increases the risk of low- and high-grade prostate cancer, while obesity in white men moderately reduces the risk of low-grade cancer and only slightly increases the risk of high-grade cancer, according to the first large, prospective study to examine how race and obesity jointly affect prostate cancer risk.

16 Apr 2015

President Bill Clinton honored with inaugural Tina's Wish Global Women's Health Award

Tina's Wish, the only nonprofit organization dedicated exclusively to funding research for the early detection of ovarian cancer, honored President Bill Clinton with the inaugural Tina's Wish Global Women's Health Award at a reception at the Waldorf Astoria New York on April 14th.

16 Apr 2015

Precision for Medicine announces acquisition of Precision Health Economics

Precision for Medicine, a specialized services company supporting next-generation approaches to drug development and commercialization, today announced the acquisition of Precision Health Economics.

16 Apr 2015

Study provides detailed brain map of language impairments in aphasia after stroke

The exchange of words, speaking and listening in conversation, may seem unremarkable for most people, but communicating with others is a challenge for people who have aphasia, an impairment of language that often happens after stroke or other brain injury.

16 Apr 2015

RegeneRx joint venture retains Ora to carry out RGN-259/GBT201 clinical trials in U.S.

RegeneRx Biopharmaceuticals, Inc. today announced its U.S. joint venture with G-treeBNT (ReGenTree LLC) has retained Ora, Inc. to conduct a phase 3 clinical trial for the orphan disorder, neurotrophic keratopathy (NK), and a 2b/3 dose-response, confirmatory trial for dry eye syndrome (DES) in the U.S. Both trials will be testing ReGenTree's preservative-free eye drops, RGN-259/GBT201, this year.

16 Apr 2015

Children who experience multiple traumatic events face risk of being hypertensive adults

Children who experience multiple traumatic events, from emotional and sexual abuse to neglect, have higher blood pressures as young adults than their peers, researchers report.

16 Apr 2015

Electronic micropump combined with anticonvulsant drug may treat brain diseases

Many potentially efficient drugs have been created to treat neurological disorders, but they cannot be used in practice. Typically, for a condition such as epilepsy, it is essential to act at exactly the right time and place in the brain.

16 Apr 2015

DPS Health introduces Virtual Lifestyle Management, forms partnership with Stanford Patient Education Research Center

DPS Health, a leader in digital behavior change interventions for emergent-risk populations, announced today the launch of its health self-management solution. Designed for health plans, providers systems and employers that are setting population health strategies for the emergent-risk population – adults with one or more pre-chronic or early-stage chronic conditions – the solution includes multi-channel consumer engagement to educate and enroll populations, Virtual Lifestyle ManagementTM to help individuals embrace healthy lifestyles, and a suite of condition-based, self-management programs to help the same individuals manage the impact of one or more conditions.

16 Apr 2015

Baxter submits BAX 855 NDA to Japan's MHLW for treatment of hemophilia A patients

Nektar Therapeutics reported today that partner Baxter International Inc. announced that the company has submitted a new drug application (NDA) to Japan's Ministry of Health, Labour and Welfare for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment based on ADVATE [Antihemophilic Factor (Recombinant)] for patients over 12 years of age with hemophilia A.

From Baxter International Inc. 16 Apr 2015

Dow, Habitat for Humanity expand partnership to address global housing, sanitation issues

The Dow Chemical Company and Habitat for Humanity announced today plans to expand their partnership in 2015 to address global housing and sanitation issues, helping thousands of families across five continents create decent, affordable housing. With first-time builds in Ethiopia, Argentina, Colombia and Nepal, Dow is increasing its support to a total of 30 countries since becoming Habitat's first national partner in 1983.

16 Apr 2015

LifeThreads introduces new line of antimicrobial linens

A new line of antimicrobial linens that inhibit the growth of bacteria on their surface are being introduced by LifeThreads LLC here at the Clean Show 2015, booth 4116, at the Georgia World Congress Center.

16 Apr 2015

ChemRar, Lancet partner to develop and commercialize new medicines in Russia

ChemRar High Tech Center, the Russian pharmaceutical investment and R&D group, and Lancet, Russian Distribution Company, have announced collaboration for research, development and commercialization of new medicines in Russia with the intention to stimulate the innovative development of the Russian pharmaceutical industry.

16 Apr 2015

Medical News

James Allison to be honored with 2015 Pezcoller Foundation-AACR International Award for Cancer Research

Aspirin use continues to surge among older adults in US

Zinc deficiency can activate Hedgehog signaling pathway

Study could lead to new therapeutic targets for treating Huntington's disease

Donald S. Coffey to receive Margaret Foti Award at AACR Annual Meeting 2015

New method for measuring genetic variability may help identify patients with aggressive cancers

CiRA, Takeda collaborate to develop clinical applications of iPS cells

Robert B. Kiningham receives Founders' Award at 2015 AMSSM Annual Meeting

Obesity in African-American men increases prostate cancer risk

President Bill Clinton honored with inaugural Tina's Wish Global Women's Health Award

Precision for Medicine announces acquisition of Precision Health Economics

Study provides detailed brain map of language impairments in aphasia after stroke

RegeneRx joint venture retains Ora to carry out RGN-259/GBT201 clinical trials in U.S.

Children who experience multiple traumatic events face risk of being hypertensive adults

Electronic micropump combined with anticonvulsant drug may treat brain diseases

DPS Health introduces Virtual Lifestyle Management, forms partnership with Stanford Patient Education Research Center

Baxter submits BAX 855 NDA to Japan's MHLW for treatment of hemophilia A patients

Dow, Habitat for Humanity expand partnership to address global housing, sanitation issues

LifeThreads introduces new line of antimicrobial linens

ChemRar, Lancet partner to develop and commercialize new medicines in Russia

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News